PAVmed Inc.
PAVM
$9.11
-$0.22-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 940.00% | -16.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 940.00% | -16.67% | |||
| Cost of Revenue | 54.55% | 34.15% | |||
| Gross Profit | 34.00% | -42.86% | |||
| SG&A Expenses | 33.35% | -4.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 41.37% | 2.71% | |||
| Operating Income | -40.44% | -2.74% | |||
| Income Before Tax | 54.13% | 51.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.13% | 51.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 137.90% | 55.83% | |||
| Net Income | 76.54% | 54.84% | |||
| EBIT | -40.44% | -2.74% | |||
| EBITDA | -40.71% | -2.75% | |||
| EPS Basic | 105.15% | 60.10% | |||
| Normalized Basic EPS | 110.64% | 47.40% | |||
| EPS Diluted | 53.81% | 60.33% | |||
| Normalized Diluted EPS | 110.64% | 47.40% | |||
| Average Basic Shares Outstanding | 24.59% | 19.19% | |||
| Average Diluted Shares Outstanding | 24.59% | 19.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||